Skip to main content
Top
Published in: Cancer Causes & Control 2/2013

01-02-2013 | Original paper

Body size and risk of Hodgkin’s lymphoma by age and gender: a population-based case–control study in Connecticut and Massachusetts

Authors: Qian Li, Ellen T. Chang, Bryan A. Bassig, Min Dai, Qin Qin, Yongshun Gao, Yawei Zhang, Tongzhang Zheng

Published in: Cancer Causes & Control | Issue 2/2013

Login to get access

Abstract

Purpose

Descriptive studies have indicated a rising trend in Hodgkin’s lymphoma (HL) incidence in young adults, especially females. Increasing evidence has suggested that some risk factors associated with HL may vary by age or gender. Recent studies have reported an increased risk of HL associated with increasing body mass index (BMI), but the results have been inconsistent. The objectives of this study were to examine whether the associations between measures of body size (height, weight, and BMI) and HL risk vary by age and/or gender.

Methods

A population-based case–control study was conducted in Connecticut and Massachusetts. A total of 567 HL cases and 679 controls were recruited in 1997–2000. Unconditional logistic regression was used to calculate odds ratios (ORs) and 95 % confidence intervals (CIs).

Results

Among younger women <35 years old, being overweight (25–29.9 kg/m2) versus normal weight (18.5–24.9 kg/m2) was significantly associated with an increased risk of HL (OR = 2.1, 95 % CI = 1.1–4.0). The risk increased with increasing weight and BMI (p trends <0.01). Among women ≥35 years old, by contrast, higher weight and BMI were associated with a reduced risk of HL (p trends <0.01). Conversely, there was no significant association between BMI and risk of HL in younger or older males.

Conclusions

These findings show that the associations between body size and risk of HL vary by gender and age, and require confirmation in other populations.
Literature
1.
go back to reference Howlader NNA, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2012) SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations). National Cancer Institute, Bethesda Howlader NNA, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2012) SEER cancer statistics review, 1975–2009 (Vintage 2009 Populations). National Cancer Institute, Bethesda
2.
go back to reference Chen YT, Zheng T, Chou MC, Boyle P, Holford TR (1997) The increase of Hodgkin’s disease incidence among young adults. Experience in Connecticut, 1935–1992. Cancer 79:2209–2218PubMedCrossRef Chen YT, Zheng T, Chou MC, Boyle P, Holford TR (1997) The increase of Hodgkin’s disease incidence among young adults. Experience in Connecticut, 1935–1992. Cancer 79:2209–2218PubMedCrossRef
4.
go back to reference Glaser SL, Swartz WG (1990) Time trends in Hodgkin’s disease incidence. The role of diagnostic accuracy. Cancer 66:2196–2204PubMedCrossRef Glaser SL, Swartz WG (1990) Time trends in Hodgkin’s disease incidence. The role of diagnostic accuracy. Cancer 66:2196–2204PubMedCrossRef
5.
go back to reference Glaser SL (1986) Recent incidence and secular trends in Hodgkin’s disease and its histologic subtypes. J Chronic Dis 39:789–798PubMedCrossRef Glaser SL (1986) Recent incidence and secular trends in Hodgkin’s disease and its histologic subtypes. J Chronic Dis 39:789–798PubMedCrossRef
6.
go back to reference Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574PubMedCrossRef Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3:565–574PubMedCrossRef
8.
go back to reference Wolk A, Gridley G, Svensson M et al (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12:13–21PubMedCrossRef Wolk A, Gridley G, Svensson M et al (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12:13–21PubMedCrossRef
9.
go back to reference Kanda J, Matsuo K, Suzuki T et al (2010) Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. Int J Cancer 126:2416–2425PubMed Kanda J, Matsuo K, Suzuki T et al (2010) Association between obesity and the risk of malignant lymphoma in Japanese: a case-control study. Int J Cancer 126:2416–2425PubMed
10.
go back to reference Chang ET, Hjalgrim H, Smedby KE et al (2005) Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 97:210–218PubMedCrossRef Chang ET, Hjalgrim H, Smedby KE et al (2005) Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 97:210–218PubMedCrossRef
11.
go back to reference Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr (2006) Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17:901–909PubMedCrossRef Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr (2006) Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17:901–909PubMedCrossRef
12.
go back to reference Willett EV, Roman E (2006) Obesity and the risk of Hodgkin lymphoma (United Kingdom). Cancer Causes Control 17:1103–1106PubMedCrossRef Willett EV, Roman E (2006) Obesity and the risk of Hodgkin lymphoma (United Kingdom). Cancer Causes Control 17:1103–1106PubMedCrossRef
13.
go back to reference Engeland A, Tretli S, Hansen S, Bjorge T (2007) Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol 165:44–52PubMedCrossRef Engeland A, Tretli S, Hansen S, Bjorge T (2007) Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol 165:44–52PubMedCrossRef
14.
go back to reference Bosetti C, Dal Maso L, Negri E et al (2005) Re: body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 97:860–861PubMedCrossRef Bosetti C, Dal Maso L, Negri E et al (2005) Re: body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst 97:860–861PubMedCrossRef
15.
go back to reference Lim U, Morton LM, Subar AF et al (2007) Alcohol, smoking, and body size in relation to incident Hodgkin’s and non-Hodgkin’s lymphoma risk. Am J Epidemiol 166:697–708PubMedCrossRef Lim U, Morton LM, Subar AF et al (2007) Alcohol, smoking, and body size in relation to incident Hodgkin’s and non-Hodgkin’s lymphoma risk. Am J Epidemiol 166:697–708PubMedCrossRef
16.
go back to reference Larsson SC, Wolk A (2011) Body mass index and risk of non-Hodgkin’s and Hodgkin’s lymphoma: a meta-analysis of prospective studies. Eur J Cancer 47:2422–2430PubMedCrossRef Larsson SC, Wolk A (2011) Body mass index and risk of non-Hodgkin’s and Hodgkin’s lymphoma: a meta-analysis of prospective studies. Eur J Cancer 47:2422–2430PubMedCrossRef
17.
go back to reference Keegan TH, Glaser SL, Clarke CA et al (2006) Body size, physical activity, and risk of Hodgkin’s lymphoma in women. Cancer Epidemiol Biomarkers Prev 15:1095–1101PubMedCrossRef Keegan TH, Glaser SL, Clarke CA et al (2006) Body size, physical activity, and risk of Hodgkin’s lymphoma in women. Cancer Epidemiol Biomarkers Prev 15:1095–1101PubMedCrossRef
18.
go back to reference Soderberg KC, Kaprio J, Verkasalo PK et al (2009) Overweight, obesity and risk of haematological malignancies: a cohort study of Swedish and Finnish twins. Eur J Cancer 45:1232–1238PubMedCrossRef Soderberg KC, Kaprio J, Verkasalo PK et al (2009) Overweight, obesity and risk of haematological malignancies: a cohort study of Swedish and Finnish twins. Eur J Cancer 45:1232–1238PubMedCrossRef
19.
go back to reference Armstrong AA, Alexander FE, Cartwright R et al (1998) Epstein-Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis. Leukemia 12:1272–1276PubMedCrossRef Armstrong AA, Alexander FE, Cartwright R et al (1998) Epstein-Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis. Leukemia 12:1272–1276PubMedCrossRef
20.
go back to reference Chang ET, Zheng T, Lennette ET et al (2004) Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma. J Infect Dis 189:2271–2281PubMedCrossRef Chang ET, Zheng T, Lennette ET et al (2004) Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma. J Infect Dis 189:2271–2281PubMedCrossRef
21.
go back to reference Bohlke K, Harlow BL, Cramer DW, Spiegelman D, Mueller NE (1999) Evaluation of a population roster as a source of population controls: the Massachusetts resident lists. Am J Epidemiol 150:354–358PubMedCrossRef Bohlke K, Harlow BL, Cramer DW, Spiegelman D, Mueller NE (1999) Evaluation of a population roster as a source of population controls: the Massachusetts resident lists. Am J Epidemiol 150:354–358PubMedCrossRef
22.
go back to reference US Census Bureau (2002) 2000 census of population and housing, summary file 3[Connecticut]. US Census Bureau, Washington US Census Bureau (2002) 2000 census of population and housing, summary file 3[Connecticut]. US Census Bureau, Washington
23.
go back to reference Chang ET, Zheng T, Weir EG et al (2004) Childhood social environment and Hodgkin’s lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev 13:1361–1370PubMed Chang ET, Zheng T, Weir EG et al (2004) Childhood social environment and Hodgkin’s lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev 13:1361–1370PubMed
24.
go back to reference Chang ET, Zheng T, Weir EG et al (2004) Aspirin and the risk of Hodgkin’s lymphoma in a population-based case-control study. J Natl Cancer Inst 96:305–315PubMedCrossRef Chang ET, Zheng T, Weir EG et al (2004) Aspirin and the risk of Hodgkin’s lymphoma in a population-based case-control study. J Natl Cancer Inst 96:305–315PubMedCrossRef
25.
go back to reference Morton LM, Turner JJ, Cerhan JR et al (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the pathology working group of the international lymphoma epidemiology consortium (InterLymph). Blood 110:695–708PubMedCrossRef Morton LM, Turner JJ, Cerhan JR et al (2007) Proposed classification of lymphoid neoplasms for epidemiologic research from the pathology working group of the international lymphoma epidemiology consortium (InterLymph). Blood 110:695–708PubMedCrossRef
26.
go back to reference Ambinder RF, Mann RB (1994) Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol 25:602–605PubMedCrossRef Ambinder RF, Mann RB (1994) Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications. Hum Pathol 25:602–605PubMedCrossRef
27.
go back to reference Gulley ML, Glaser SL, Craig FE et al (2002) Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol 117:259–267PubMedCrossRef Gulley ML, Glaser SL, Craig FE et al (2002) Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol 117:259–267PubMedCrossRef
28.
go back to reference Organization WH (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser Organization WH (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser
29.
go back to reference Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79:340–349PubMedCrossRef Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79:340–349PubMedCrossRef
30.
go back to reference Miller AB, Barclay TH, Choi NW et al (1980) A study of cancer, parity and age at first pregnancy. J Chronic Dis 33:595–605PubMedCrossRef Miller AB, Barclay TH, Choi NW et al (1980) A study of cancer, parity and age at first pregnancy. J Chronic Dis 33:595–605PubMedCrossRef
31.
go back to reference Olsson H, Olsson ML, Ranstam J (1990) Late age at first full-term pregnancy as a risk factor for women with malignant lymphoma. Neoplasma 37:185–190PubMed Olsson H, Olsson ML, Ranstam J (1990) Late age at first full-term pregnancy as a risk factor for women with malignant lymphoma. Neoplasma 37:185–190PubMed
32.
go back to reference Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMedCrossRef Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578PubMedCrossRef
33.
34.
go back to reference Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215–244PubMedCrossRef Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215–244PubMedCrossRef
35.
go back to reference Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34PubMed Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3–34PubMed
36.
go back to reference Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM (2001) Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 23:313–342PubMedCrossRef Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM (2001) Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 23:313–342PubMedCrossRef
37.
go back to reference Okasha M, Gunnell D, Holly J, Davey Smith G (2002) Childhood growth and adult cancer. Best Pract Res Clin Endocrinol Metab 16:225–241PubMedCrossRef Okasha M, Gunnell D, Holly J, Davey Smith G (2002) Childhood growth and adult cancer. Best Pract Res Clin Endocrinol Metab 16:225–241PubMedCrossRef
38.
go back to reference Cunningham AS (1981) Childhood social environment and Hodgkin’s disease. N Engl J Med 304:1170–1171 Cunningham AS (1981) Childhood social environment and Hodgkin’s disease. N Engl J Med 304:1170–1171
39.
go back to reference Isager H, Andersen E (1978) Pre-morbid factors in Hodgkin’s disease. I. Birth weight and growth pattern from 8 to 14 years of age. Scand J Haematol 21:250–255PubMedCrossRef Isager H, Andersen E (1978) Pre-morbid factors in Hodgkin’s disease. I. Birth weight and growth pattern from 8 to 14 years of age. Scand J Haematol 21:250–255PubMedCrossRef
40.
go back to reference Pui CH, Dodge RK, George SL, Green AA (1987) Height at diagnosis of malignancies. Arch Dis Child 62:495–499PubMedCrossRef Pui CH, Dodge RK, George SL, Green AA (1987) Height at diagnosis of malignancies. Arch Dis Child 62:495–499PubMedCrossRef
42.
go back to reference Gutensohn N, Cole P (1981) Childhood social environment and Hodgkin’s disease. N Engl J Med 304:135–140PubMedCrossRef Gutensohn N, Cole P (1981) Childhood social environment and Hodgkin’s disease. N Engl J Med 304:135–140PubMedCrossRef
43.
go back to reference Paffenbarger RS Jr, Wing AL, Hyde RT (1977) Characteristics in youth indicative of adult-onset Hodgkin’s disease. J Natl Cancer Inst 58:1489–1491PubMed Paffenbarger RS Jr, Wing AL, Hyde RT (1977) Characteristics in youth indicative of adult-onset Hodgkin’s disease. J Natl Cancer Inst 58:1489–1491PubMed
44.
go back to reference Kravdal O, Hansen S (1993) Hodgkin’s disease: the protective effect of childbearing. Int J Cancer 55:909–914PubMedCrossRef Kravdal O, Hansen S (1993) Hodgkin’s disease: the protective effect of childbearing. Int J Cancer 55:909–914PubMedCrossRef
Metadata
Title
Body size and risk of Hodgkin’s lymphoma by age and gender: a population-based case–control study in Connecticut and Massachusetts
Authors
Qian Li
Ellen T. Chang
Bryan A. Bassig
Min Dai
Qin Qin
Yongshun Gao
Yawei Zhang
Tongzhang Zheng
Publication date
01-02-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 2/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0100-1

Other articles of this Issue 2/2013

Cancer Causes & Control 2/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine